| First Author | Vi L | Year | 2011 |
| Journal | J Invest Dermatol | Volume | 131 |
| Issue | 3 | Pages | 586-93 |
| PubMed ID | 21150927 | Mgi Jnum | J:182088 |
| Mgi Id | MGI:5314700 | Doi | 10.1038/jid.2010.362 |
| Citation | Vi L, et al. (2011) Integrin-linked kinase is required for TGF-beta1 induction of dermal myofibroblast differentiation. J Invest Dermatol 131(3):586-93 |
| abstractText | Cutaneous repair after injury requires activation of resident dermal fibroblasts and their transition to myofibroblasts. The key stimuli for myofibroblast formation are activation of transforming growth factor-beta (TGF-beta) receptors and mechanotransduction mediated by integrins and associated proteins. We investigated the role of integrin-linked kinase (ILK) in TGF-beta1 induction of dermal fibroblast transition to myofibroblasts. ILK-deficient fibroblasts treated with TGF-beta1 exhibited attenuation of Smad 2 and 3 phosphorylation, accompanied by impaired transcriptional activation of Smad targets, such as alpha-smooth muscle actin. These alterations were not limited to Smad-associated TGF-beta1 responses, as stimulation of noncanonical mitogen-activated protein kinase pathways by this growth factor was also diminished in the absence of ILK. ILK-deficient fibroblasts exhibited abnormalities in the actin cytoskeleton, and did not form supermature focal adhesions or contractile F-actin stress fibers, indicating a severe impairment in their capacity to differentiate into myofibroblasts. These defects extended to the inability of cells to contract extracellular matrices when embedded in collagen lattices. We conclude that ILK is necessary to transduce signals implicated in the transition of dermal fibroblasts to myofibroblasts originating from matrix substrates and TGF-beta1. |
